Katherine A. Buzzard

Level 6, 99 Commercial Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 03, 2026

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 01, 2026

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors.

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors.

Journal: Internal medicine journal

Published: May 28, 2026

Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.

Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.

Journal: Frontiers in neurology

Published: May 16, 2026

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Journal: Autoimmunity reviews

Published: May 11, 2026

Corrigendum to "Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study" [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885].

Corrigendum to "Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study" [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885].

Journal: Multiple sclerosis and related disorders

Published: April 10, 2026

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Journal: Brain : a journal of neurology

Published: March 12, 2026

Plasma proteome in LGI-1 autoimmune encephalitis.

Plasma proteome in LGI-1 autoimmune encephalitis.

Journal: Journal of neuroinflammation

Published: February 23, 2026

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 13, 2026

Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis.

Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis.

Journal: Journal of neurology

Published: January 11, 2026

Managing reactivation of multiple sclerosis during treatment with natalizumab.

Managing reactivation of multiple sclerosis during treatment with natalizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 20, 2025

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Journal: Journal of neurology

Published: November 01, 2025

Showing 1-12 of 112

Last Updated: 09/26/2026